QIM
MACK

Quantitative Investment Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Quantitative Investment Management’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-54,526
Closed -$623K – 949
2017
Q3 		$623K Buy
+54,526
New +$573K 0.01% 596
2015
Q3 		– Sell
-1,716
Closed -$166K – 846
2015
Q2 		$166K Buy
+1,716
New +$163K 0.03% 399
2014
Q4 		– Sell
-2,313
Closed -$159K – 630
2014
Q3 		$159K Buy
2,313
+457
+25% +$24.4K 0.03% 307
2014
Q2 		$106K Buy
1,856
+77
+4% +$3.91K 0.02% 434
2014
Q1 		$70K Buy
+1,779
New +$76.1K ﹤0.01% 513

Other funds holding MACK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Quantitative Investment Management's MACK Position: Q4 2017 in Review

Quantitative Investment Management sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q4 2017, closing a stake of 54,526 shares — an estimated $623K sold.

Quantitative Investment Management first reported a position in MACK in Q1 2014 and held it in 5 quarters. The position peaked at $623K in Q3 2017. 78 funds tracked by Wall St. Rank hold MACK as of Q4 2017.

  • Quantitative Investment Management reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
  • Quantitative Investment Management sold 54,526 Merrimack Pharmaceuticals, Inc. shares in Q4 2017, an estimated $623K.
  • Quantitative Investment Management first reported a position in Merrimack Pharmaceuticals, Inc. in Q1 2014 and held it in 5 quarters.
  • Quantitative Investment Management's Merrimack Pharmaceuticals, Inc. position peaked at $623K in Q3 2017.
  • 78 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q4 2017.

Based on Quantitative Investment Management's 13F filing for Q4 2017, filed 14 Feb 2018.